Phase 2 data presented at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting show deep and durable tumor regressions in heavily pre-treated melanoma patients, with a mild safety ...
Medpage Today on MSN
FDA Approves IV Antibiotic for Complicated UTIs
The FDA approved an intravenous (IV) formulation of fosfomycin (Contepo) to treat adults with complicated urinary tract ...
Down-titrating vial concentrations when restarting subcutaneous allergen immunotherapy after treatment gaps may help lower ...
The combination of talquetamab (Talvey) and daratumumab (Darzalex) demonstrated promising and robust clinical activity for ...
First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...
Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback